CYCN: Cyclerion Therapeutics, Inc. Stock

by  •  • Comments Off on CYCN: Cyclerion Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.43
Enterprise Value ($M) 3.56
Book Value ($M) 8.20
Book Value / Share 3.24
Price / Book 0.78
NCAV ($M) 2.85
NCAV / Share 1.13
Price / NCAV 2.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.64
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.47

Liquidity (mrq)
Quick Ratio 5.07
Current Ratio 5.07

Balance Sheet (mrq) ($M)
Current Assets 3.55
Assets 8.90
Liabilities 0.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-06 13G/A Slate Path Capital LP
07-12 13G/A Artal International S.C.A. 4.30 -16.41
02-14 13G/A Tyndall Capital Partners L P 6.70 35.18
02-09 13G/A Fmr Llc 6.66

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 29,641,959 76,317,144 38.84
2025-01-30 12,538 47,732 26.27
2025-01-29 1,670 8,078 20.67
2025-01-28 10,578 40,239 26.29
2025-01-27 10,756 23,620 45.54

(click for more detail)

Similar Companies
CUE – Cue Biopharma, Inc. CVKD – Cadrenal Therapeutics, Inc.
CYCC – Cyclacel Pharmaceuticals, Inc. CYRX – Cryoport, Inc.
CYTH – Cyclo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io